Your browser doesn't support javascript.
loading
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma.
McDermott, David F; Lee, Jae-Lyun; Bjarnason, Georg A; Larkin, James M G; Gafanov, Rustem A; Kochenderfer, Mark D; Jensen, Niels Viggo; Donskov, Frede; Malik, Jahangeer; Poprach, Alexandr; Tykodi, Scott S; Alonso-Gordoa, Teresa; Cho, Daniel C; Geertsen, Poul F; Climent Duran, Miguel Angel; DiSimone, Christopher; Silverman, Rachel Kloss; Perini, Rodolfo F; Schloss, Charles; Atkins, Michael B.
Afiliación
  • McDermott DF; Dana-Farber/Harvard Cancer Center, Boston, MA.
  • Lee JL; Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Bjarnason GA; Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.
  • Larkin JMG; Institute of Cancer Research, London, UK.
  • Gafanov RA; Russian Scientific Center of Roentgen Radiology, Moscow, Russia.
  • Kochenderfer MD; Carilion Clinic, Roanoke, VA.
  • Jensen NV; Odense University Hospital, Odense, Denmark.
  • Donskov F; Aarhus University Hospital, Aarhus, Denmark.
  • Malik J; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
  • Poprach A; Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic.
  • Tykodi SS; University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Alonso-Gordoa T; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Cho DC; Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY.
  • Geertsen PF; Herlev Hospital, University of Copenhagen, Herlev, Denmark.
  • Climent Duran MA; Instituto Valenciano de Oncología, València, Spain.
  • DiSimone C; Arizona Oncology/US Oncology, Tucson AZ.
  • Silverman RK; Merck & Co, Inc, Kenilworth, NJ.
  • Perini RF; Merck & Co, Inc, Kenilworth, NJ.
  • Schloss C; Merck & Co, Inc, Kenilworth, NJ.
  • Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.
J Clin Oncol ; 39(9): 1020-1028, 2021 03 20.
Article en En | MEDLINE | ID: mdl-33529051
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Marruecos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Marruecos